All posts
12479 total · page 1 of 250
TiCK Solutions Global Launches 10-Minute At-Home Tick Test
TiCK Solutions Global unveils TiCK TEST, a rapid diagnostic tool for Lyme disease detection at home.
Global Point of Care Diagnostics Market Projected to Expand Through 2031
The Point of Care Diagnostics market is poised for growth, driven by advancements in technology and increasing demand across regions.
AI Advances in Vitiligo Care: Transforming Dermatology Practices
AI is revolutionizing vitiligo treatment, enhancing diagnostics and personalized care.
BEEPER Study: New Pediatric Rule Excludes Pulmonary Embolism Without Radiation
The BEEPER study introduces the PERC-Peds rule, offering a radiation-free method for excluding pulmonary embolism in children.
AI's Role in Bedside Diagnosis: Challenges and Strategies
AI is transforming bedside diagnostics, raising questions about its impact on patient care and healthcare practices.
Innovative Transistor Design Enhances Wearable E-Skin Precision
Researchers unveil a new transistor design that boosts the accuracy of wearable electronic skin, promising advancements in health monitoring technologies.
New Dataset Enhances Stroke Rehabilitation with Wearable Sensors
Researchers have created a kinematic dataset using wearable sensors to aid rehabilitation in 120 post-stroke patients.
Aston University Develops Wearable Sensor to Detect Stress and Anxiety
Aston University has unveiled a new wearable sensor capable of identifying early signs of stress and anxiety, promising advancements in mental health monitoring.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion and Stake Sale
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, eyeing global market growth.
Medical Device Sector Challenges Draft Bill's Pharma-Like Regulations
India's medical device industry opposes a draft bill equating devices with drugs, citing risks to innovation and investment.
Molbio Diagnostics' IPO: A High-Risk Opportunity for Investors
Molbio Diagnostics seeks ₹940 crore via IPO to fund expansion and reduce promoter stakes, appealing to high-risk investors.
Medical Device Industry Challenges Draft Bill Treating Devices as Pharma
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Fill Finish Manufacturing Market Poised for Growth by 2035
The fill finish manufacturing market is set for significant expansion by 2035, driven by advancements in pharmaceutical production and growing demand for biologics.
Innovations in Sterile Product Development for Pharma Manufacturing
Pharma firms are revamping sterile product development to boost manufacturing efficiency and ensure safety.
Halo Unveils Versatile Sterile Fill-Finish Line
Halo introduces a new platform for sterile fill-finish, accommodating three formats on a single line.
Gland Pharma Enters CDMO Agreement for Sterile Injectables
Gland Pharma partners with a CDMO to enhance its sterile injectables manufacturing capabilities.
BioHarvest Sciences Inks Major Fragrance Contract, Eyes 2027 Profitability
BioHarvest Sciences secures a key fragrance contract, boosting revenue and aiming for 2027 EBITDA breakeven.
BioHarvest Sciences Lowers FY26 Revenue Forecast for CDMO and VINIA D2C
BioHarvest revises FY26 revenue projections downward for its CDMO and VINIA D2C segments, reflecting market challenges.
NITI Aayog Unveils Latest 'Trade Watch Quarterly' Edition
NITI Aayog has released the eighth edition of its 'Trade Watch Quarterly', offering insights into India's trade dynamics.
APIs Revolutionize Access to Real-Time Global Tariff Data
Global trade experts increasingly rely on APIs for accurate, up-to-date tariff information, enhancing decision-making and compliance.
India's Pharma Exports Overtake Imports, Reaching Rs 41,500 Cr in FY25
India's pharmaceutical sector sees a boost as exports of active ingredients surpass imports, marking a significant trade milestone.
Molbio Diagnostics Eyes ₹200 Crore Through IPO Amidst Global Expansion
Molbio Diagnostics plans to raise ₹200 crore via IPO for expansion, while reducing promoter stake to 43%.
Ebola Death Toll Surpasses 2,000 in DRC Amid Vaccine Efforts
Ebola fatalities in the DRC have exceeded 2,000, prompting urgent calls for vaccine development and community-led containment strategies.
Medical Device Firms Oppose Bill Equating Devices with Drugs
India's medical device sector challenges a draft bill treating devices as pharmaceuticals, citing regulatory and innovation concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO Amidst Global Expansion
Molbio Diagnostics is launching an IPO to raise ₹940 crore, aiming to bolster capital expenditures and reduce promoter stake.
Indian Medical Device Industry Rejects Equating Devices with Pharma in New Bill
Industry leaders argue the Draft Bill's pharma-style regulations threaten innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fund Expansion
Molbio Diagnostics seeks to raise ₹940 crore through IPO for expansion and stake reduction, targeting long-term growth.
Medical Device Industry Challenges India's Draft Regulation Bill
India's medical device sector opposes the draft bill treating devices like drugs, citing potential harm to innovation and investment.
Molbio Diagnostics IPO: A High-Risk Bet for Potential Long-Term Gains
Molbio Diagnostics seeks to raise ₹940 crore via IPO to fund expansion and reduce promoter stake. Investors weigh high-risk, high-reward potential.
Industry Criticizes Draft Bill for Treating Medical Devices as Drugs
The medical device sector opposes the 2026 draft bill, arguing it aligns devices with pharmaceuticals, risking innovation and growth.
Molbio Diagnostics' IPO: A High-Risk Opportunity for Investors
Molbio Diagnostics seeks to raise ₹940 crore via IPO to fund expansion and promoter stake reduction.
Trump Alters Childhood Vaccine Schedule Amid Criticism
President Trump signs an executive order changing the childhood vaccine schedule, sparking controversy.
Medical Device Firms Oppose Draft Bill Treating Devices as Drugs
India's medical device sector challenges draft bill equating devices with pharmaceuticals, fearing impacts on innovation and investment.
Bangladesh to Launch Nationwide Health Screening Initiative
Bangladesh is set to introduce a door-to-door health screening program, aiming to improve access to medical care across the country.
Beyond Checkups: Comprehensive Health for Executives Gains Urgency
Executives are shifting towards comprehensive health strategies that extend beyond routine checkups to safeguard their well-being.
Health Challenges Loom Over U.S. C-Suite Executives
U.S. executives face increasing health issues, impacting business productivity.
Ivory Launches Initiative to Screen for Mental Health Risks
Ivory introduces a proactive brain screening program to detect mental health issues before they manifest.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, aiming to bolster its global diagnostics footprint.
Healthcare Shift Workers Face Increased Respiratory Infections
Shift workers in healthcare see a rise in respiratory infections, raising health concerns.
Delhi Sees Alarming Six-Fold Surge in H1N1 Cases
Delhi reports a dramatic rise in H1N1 cases, surging six-fold compared to last year, raising health concerns.
Rise in Lung Cancer Cases Among Non-Smokers Raises Alarm
Lung cancer is increasingly affecting non-smokers due to factors like air pollution and genetic predispositions.
AI Breakthrough Offers New Fertility Hope for Men with Low Sperm Counts
AI technology is revolutionizing fertility treatment by identifying viable sperm in men with low sperm counts, enhancing chances for biological parenthood.
Medical Device Sector Challenges India's New Regulatory Bill
Industry opposes treating devices as drugs in the draft Drugs, Medical Devices, and Cosmetics Bill 2026.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO, aiming to expand and reduce promoter stake.
Medical Device Industry Pushes Back Against India's Draft Bill 2026
India's medical device sector challenges the 2026 Draft Bill, warning it stifles innovation by equating devices with pharmaceuticals.
Molbio Diagnostics Eyes ₹940 Crore from IPO, Targets High-Risk Investors
Molbio Diagnostics plans to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake.
Medical Device Industry Challenges Draft Bill on Regulatory Grounds
India's medical device industry rejects draft bill equating devices to drugs, citing risks to innovation and investment.
Molbio Diagnostics Eyes ₹200 Crore IPO for Expansion Amid Growth
Molbio Diagnostics plans a ₹200 crore IPO to boost capital expenditures and reduce promoter stake, following strong revenue growth.
Rising Recall Fatigue Amid Surging Food Safety Alerts
Amid a surge in food recalls, consumers grow weary as cyclospora and salmonella outbreaks trouble major food chains.
Expert Insights: Debunking Myths on Water Intake and Sleep
Dr. John Torres addresses common health myths, focusing on water intake and sleep advice.